• COMPANY
    • LEADERSHIP
    • CAREERS
    • NIH GRANT SUPPORT
    • CONTACT US
    • Non Gamstop Casinos
    • Casinos Not On Gamstop
  • TECHNOLOGY
  • APPLICATIONS
    • ALLOSTERIC TARGETS
    • SECONDARY SCREENING & MECHANISM OF ACTION
    • COMPLEX TARGETS
    • TRUBIND AT WORK
      • ION CHANNEL INHIBITORS
      • PPI INTERACTIONS
      • TARGETING GPCRs
      • KINASE INTERACTIONS
  • DRUG DISCOVERY SERVICES
    • Assay Development
    • Secondary Screening
    • Binding Characterization Process
    • PHARMACEUTICAL PROJECTS
  • PRODUCTS
  • LITERATURE
  • NEWS
  • EVENTS
    • On-Demand Webinars
    • Exhibitions
DRUG DISCOVERY SERVICES PHARMACEUTICAL PROJECTS

Tested Solutions by World Class Pharmaceutical Clients

A majority of the top ten pharmaceutical and biotechnology companies worldwide have collaborated with Molecular Sensing to solve high value drug binding characterization problems impacting early discovery through IND submission. Our client partners include leading biophysics, medicinal chemistry, pharmacology and various disease project groups.


Advantages of TrubindTM Assay & System Integration

  • • Provides valuable data for your high value project
  • • De-risks new technology acquisition
  • • Guarantees success of integrated assay with system
  • • Includes discount valued at the cost of Phase 1
  • • Delivers the instrument on a priority basis

 


 

READ ABOUT OUR BINDING CHARACTERIZATION PROCESS>

DRUG DISCOVERY SERVICES

  • ASSAY DEVELOPMENT
  • SECONDARY SCREENING
  • BINDING CHARACTERIZATION PROCESS
  • PHARMACEUTICAL PROJECTS

ON-DEMAND WEBINARS

  • Interrogating Ligand: Target Interactions Using Back-Scattering Interferometry Yields Mechanistic Insight and Aids in Compound PrioritizationBy MSI on January 26, 2016
  • Review of Recent Publications Featuring Binding Data Produced by MSIBy MSI on January 26, 2016
  • Conformation-Sensitive Assay Detection for Accelerated Drug Discovery ResearchBy MSI on February 10, 2015
  • Evaluation of the MoA of Allosteric Modulators and Its Application to Drug Discovery using Back-Scattering InterferometryBy MSI on November 13, 2014
  • Using BSI to Investigate Positive Allosteric Modulators of the M4 ReceptorBy MSI on September 3, 2014

Read about our low-risk, high-value bitcoin superstar trading app. Binding Characterization Process that a majority of the top ten pharmaceutical and biotechnology companies have used to solve drug binding characterization problems impacting early discovery through IND submission.

DOWNLOAD NOW>
© Copyright 2015 by Molecular Sensing, Inc.
  • /Terms of Use
  • /Privacy Policy